Gross Profit On Sales 変化する 日付
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Agios Pharmaceuticals USD 6.52M 249K 2023-12
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amarin USD 42.5M 14.47M 2023-09
Amgen USD 5.08B 14M 2023-12
Baxter International USD 1.49B 351M 2023-12
Cara Therapeutics USD 3.31M 2.21M 2023-09
Eli Lilly USD 7.57B 73.1M 2023-12
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
MannKind USD 40.4M 3.41M 2023-12
Nektar Therapeutics USD 11.71M 1.79M 2023-09
Peregrine Pharmaceuticals USD -4665000 8.76M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Rigel Pharmaceuticals USD 26.87M 1.06M 2023-09
United Therapeutics USD 543.7M 4.4M 2023-12
Vanda Pharmaceuticals USD 42.56M 15.17M 2023-06



Halozyme Therapeutics 売上総利益 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Mar 2024.